9 research outputs found

    Additional file 1: of An improved method for functional similarity analysis of genes based on Gene Ontology

    No full text
    In the additional file, Figure S1. depecits the distributions of term IC based on CC and MF ontology for each IC calculation model. Tables S1-S4. show the functional similarity values between seleted genes for each method on the functional classification of genes in a biological pathway experiment. Table S5, Figure S2. and Figure S3. list out the accumulated results about correlations on ECC, SeqSim and Res for each method with IEA+ and IEA- on CESSM datasets. The more detail descriptions about the experimental results are shown in the Additional file 1. (PDF 448 kb

    Prediction of microRNAs Associated with Human Diseases Based on Weighted <i>k</i> Most Similar Neighbors

    Get PDF
    <div><p>Background</p><p>The identification of human disease-related microRNAs (disease miRNAs) is important for further investigating their involvement in the pathogenesis of diseases. More experimentally validated miRNA-disease associations have been accumulated recently. On the basis of these associations, it is essential to predict disease miRNAs for various human diseases. It is useful in providing reliable disease miRNA candidates for subsequent experimental studies.</p><p>Methodology/Principal Findings</p><p>It is known that miRNAs with similar functions are often associated with similar diseases and vice versa. Therefore, the functional similarity of two miRNAs has been successfully estimated by measuring the semantic similarity of their associated diseases. To effectively predict disease miRNAs, we calculated the functional similarity by incorporating the information content of disease terms and phenotype similarity between diseases. Furthermore, the members of miRNA family or cluster are assigned higher weight since they are more probably associated with similar diseases. A new prediction method, HDMP, based on weighted <i>k</i> most similar neighbors is presented for predicting disease miRNAs. Experiments validated that HDMP achieved significantly higher prediction performance than existing methods. In addition, the case studies examining prostatic neoplasms, breast neoplasms, and lung neoplasms, showed that HDMP can uncover potential disease miRNA candidates.</p><p>Conclusions</p><p>The superior performance of HDMP can be attributed to the accurate measurement of miRNA functional similarity, the weight assignment based on miRNA family or cluster, and the effective prediction based on weighted <i>k</i> most similar neighbors. The online prediction and analysis tool is freely available at <a href="http://nclab.hit.edu.cn/hdmpred" target="_blank">http://nclab.hit.edu.cn/hdmpred</a>.</p></div

    The disease DAGs of liver neoplasms and pancreatic neoplasms.

    No full text
    <p>(a) DAG of liver neoplasms. (b) DAG of pancreatic neoplasms. The nodes in blue are the disease terms shared by the two DAGs.</p

    Process of predicting disease <i>d</i>-related candidates.

    No full text
    <p>Step 1: calculate the functional similarity of any two miRNAs and construct a symmetric functional similarity matrix. Step 2: assign the members of miRNA family or cluster higher weight. Step 3: calculate the relevance score of each unlabeled miRNA. Step 4: rank all the unlabeled miRNAs according to their scores and select the top ranked miRNAs as potential candidates.</p

    Prediction results of HDMP and other methods for 5-fold cross validation.

    No full text
    <p>There are 8, 12, and 18 common diseases between HDMP and FCS method, Jiang's method, and RWRMDA, respectively. ‘No. of associated miRNAs’ indicates the number of miRNAs associated with a specific disease in September-2012 Version of HMDD.</p

    Prediction results of HDMP and other methods for updated dataset validation.

    No full text
    <p>There are 4, 7, and 9 common diseases between HDMP and FCS method, Jiang's method, and RWRMDA, respectively. ‘No. of associated miRNAs’ indicates the number of miRNAs associated with a specific disease in November-2010 Version of HMDD. ‘No. of new added miRNAs’ indicates the number of miRNAs associated with a specific disease which are added into HMDD between November-2010 and September-2012.</p
    corecore